Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Cathie Wood's ARK focuses on Teladoc and 10X Genomics stock

EditorFrank DeMatteo
Published 04/10/2024, 08:18 PM
Updated 04/10/2024, 08:18 PM
© Reuters

Cathie Wood's ARK ETF published their daily trades for Wednesday, April 10th, 2024, showcasing a series of strategic buys and sells across various sectors. The trades indicate ARK's continued interest in health technology and aerospace innovation, with significant investments in companies like Teladoc Health Inc (NYSE:TDOC) and 10X Genomics Inc (NASDAQ:TXG).

The highest dollar-value trade for the day was ARK's purchase of 600,483 shares of Teladoc Health Inc, amounting to a substantial investment of $9,043,274. This move suggests a bullish stance on the telemedicine company, which has been a recurring interest for ARK, as evidenced by their consistent buying pattern over the past week.

Another notable trade was the acquisition of 93,252 shares of 10X Genomics Inc, valued at $3,484,827. The genomics company has been another regular feature in ARK's trading activity, indicating the fund's confidence in the growth potential of genomic solutions.

In the aerospace domain, ARK showed significant interest by buying 415,239 shares of Blade Air Mobility Inc (NASDAQ:BLDE) through the ARKX ETF, with a total dollar value of $1,602,822. Additionally, the fund continued to accumulate shares of Archer Aviation Inc (NYSE:NYSE:ACHR), adding 325,945 shares for a total of $1,395,044.

On the selling side, ARK divested from several companies, including a notable sell of 24,141 shares of Coinbase Global Inc (NASDAQ:COIN), which resulted in a reduction of $5,865,055 from their holdings. This move might reflect ARK's strategy to rebalance their portfolio in light of the fluctuating cryptocurrency market.

Other sales included 20,496 shares of Exact Sciences Corp (NASDAQ:EXAS), totaling $1,522,033, and 19,1538 shares of The 3D Printing ETF (BATS:PRNT), amounting to $4,332,072. These sales may indicate ARK's shifting focus or a response to market changes.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

ARK also continued to adjust its holdings in smaller increments, with purchases of shares in companies like Iridium Communications Inc (NASDAQ:IRDM), Intellia Therapeutics Inc (NASDAQ:NTLA), and Palantir Technologies Inc (NYSE:NYSE:PLTR), as well as sales in Caterpillar Inc (NYSE:NYSE:CAT), Incyte Corp (NASDAQ:INCY), and UiPath Inc (NYSE:NYSE:PATH).

The day's trading activity reflects ARK's dynamic and responsive investment approach, with a clear focus on innovative companies poised for growth. As ARK continues to adjust its portfolio, investors and market watchers alike will be keen to follow these trades to gauge the fund's outlook on various sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.